St. Jude INSIDER
Spotlight Series

St. Jude Global®

Date: Tuesday, April 1, 2025
Time: 2 p.m. CT (3 p.m. ET)

Register Now

 
Pediatric oncologist Dr. Ricardo Solis stands beside patient Keira and her grandmother, smiling.

Pediatric oncologist Dr. Ricardo Solis with patient Keira and her grandmother at Baca Ortiz Pediatric Hospital in Quito, Ecuador

 
 

Event Information

  

You’re invited to join an exclusive group of our most loyal supporters for a special virtual event featuring:

  • Ike Anand, Interim Chief Executive Officer of ALSAC, the fundraising and awareness organization for St. Jude Children's Research Hospital
  • Dr. Carlos Rodriguez-Galindo, M.D., Executive Vice President of St. Jude Children's Research Hospital and Director of St. Jude Global

At this event, you will see first-hand the work that St. Jude is leading globally on behalf of children with cancer and other life-threatening diseases.

Today, the most significant predictor of whether a child will survive cancer is where the child lives. While survival rates have surpassed 80% in high-income countries like the U.S., low-and-middle income countries (LMICs) lag far behind, with nearly half of children with cancer undiagnosed and untreated. Unreliable access to generic, low-cost cancer drugs in LMICs often lead to treatment disruptions, poor-quality drugs and reduced survival.

We hope will you register now and join us to see how St. Jude is addressing this disparity. Generous supporters like you make this work possible and we are looking forward to having the opportunity to share this with you.

 

Featured St. Jude speakers

A portrait photo of Ike Anand, Interim CEO of ALSAC.

Ike Anand

Interim Chief Executive Officer, ALSAC

 
A portrait photo of Dr. Rodriguez-Galindo, Executive Vice President of St. Jude Children's Research Hospital.

Carlos Rodriguez-Galindo, M.D.

Executive Vice President, St. Jude Children's Research Hospital and Director of St. Jude Global

 
 
 
 

What is St. Jude Global® doing to help?

St. Jude established the St. Jude Global Alliance in 2018 to foster a global workforce, enhance regional treatment capacity and coordinate research through St. Jude Global®, a network of more than 400 institutions across more than 80 countries.

 
 
Head of Pediatric Oncology Dr. Justin Makasa Mulindwa checks on patients at the Cancer Diseases Hospital in Lusaka, Zambia.

Dr. Justin Makasa Mulindwa with patients at the Cancer Diseases Hospital in Lusaka, Zambia

 

St. Jude and WHO collaboration

In 2018, St. Jude became the first WHO Collaborating Centre for Childhood Cancer and co-launched the Global Initiative for Childhood Cancer (GICC), aiming to increase survival rates for six treatable cancers in LMICs from 20% to 60% by 2030.

St. Jude and World Health Organization (WHO) created a platform to procure and distribute generic cancer medicines to LMICs at no cost, starting with six pilot countries and expanding to 50 across six years, with a $200 million commitment from St. Jude.

UNICEF, PAHO, SIOP and CCI are involved as procurement and technical partners, ensuring quality, regulatory compliance and efficient distribution.

 
 

Your feedback is important to us.

Please share your feedback and ideas with us through our post-event emailed survey. We'll use your thoughts to inform the content and featured guests for future virtual live events. 

 
 
Graphic showcasing a global map

Asya Agulnik, M.D., M.P.H., is an assistant faculty member at St. Jude Children’s Research Hospital in the Department of Global Pediatric Medicine, with a joint appointment in the Department of Pediatrics, Division of Critical Care. Agulnik is the Director of the St. Jude Global Critical Care Program and Euro Regional Program. She is Director of SAFER Ukraine, an effort to evacuate Ukrainian children with cancer and blood disorders affected by war.

Agulnik lives in Memphis. Tennessee, where St. Jude is located, with her husband and two sons. She obtained her undergraduate degree from Harvard University in 2005. She earned a Master of Public Health degree from the University of California, Berkeley, in 2008 and obtained her medical degree from Stanford University School of Medicine in 2010.

Agulnik completed her residency (2013) in pediatrics through the Boston Combined Residency Program (Harvard and affiliated hospitals). She also completed a pediatric critical care fellowship at Boston Children’s Hospital in 2016. That year, Agulnik joined the St. Jude faculty.

Agulnik is a clinician scientist, with clinical work in the intensive care unit at St. Jude and research focused on global implementation science and improving hospital care for critically ill children with cancer.  Aglunik leads St. Jude’s Pediatric Early Warning System (PEWS), called the St. Jude Advanced Warning System (sJAWS), aimed to help identify hospitalized patients who are at high risk for clinical deterioration. Through the St. Jude Global Critical Care Program, she has supported implementation of PEWS in over 70 centers in Latin American through Proyecto EVAT. 

In 2018, Agulnik worked with regional stakeholders to start the St. Jude Global Eurasian Regional Program (now called the Euro Regional Program), which has grown to include nearly 50 institutions in 15 countries in Central Asia and Eastern Europe, including Ukraine and Poland. This collaborative program facilitated a prompt response to the war in Ukraine in February, 2022, now called the “Supporting Action for Emergency Respnose in Ukraine (SAFER Ukraine)” program, which Agulnik directs. 

Close
Close